{
  "fullName": "Robert S. Langer",
  "slug": "robert-s-langer",
  "title": "MD",
  "specialty": "Biomaterials & Drug Delivery",
  "subSpecialty": null,
  "geography": {
    "country": "United States",
    "region": null,
    "city": null
  },
  "status": "LIVING",
  "tier": "TITAN",
  "rankingScore": 28,
  "hIndex": 451,
  "yearsActive": 0,
  "verifiedSurgeries": 0,
  "livesSaved": 0,
  "biography": "Robert Samuel Langer Jr. FREng is an American biotechnologist, businessman, chemical engineer, chemist, and inventor. He is one of the nine Institute Professors at the Massachusetts Institute of Technology.",
  "aiSummary": "Robert S. Langer is a biomaterials & drug delivery specialist with an H-index of 451 at MIT (Faculty). Has been published in Science, Nature Nanotechnology, Nature Reviews Drug Discovery. Based in United States.",
  "techniquesInvented": [],
  "hasInvention": false,
  "portraitUrl": "https://upload.wikimedia.org/wikipedia/commons/thumb/c/c3/Robert_Langer_in_2023.jpg/330px-Robert_Langer_in_2023.jpg",
  "galleryUrls": [],
  "npiNumber": null,
  "orcidId": null,
  "medicalSpecialty": [
    "Biomaterials & Drug Delivery"
  ],
  "knowsAbout": [],
  "affiliations": [
    {
      "hospitalName": "MIT",
      "role": "Faculty",
      "hospitalUrl": "#"
    }
  ],
  "citations": [
    {
      "title": "Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry.",
      "journal": "Nat Mater",
      "year": 2024,
      "citationCount": 0,
      "doi": "10.1038/s41563-024-01867-3",
      "pubmedId": "38740955",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/38740955/"
    },
    {
      "title": "Klaus Mosbach tribute.",
      "journal": "Biotechnol Bioeng",
      "year": 2015,
      "citationCount": 0,
      "doi": "10.1002/bit.25507",
      "pubmedId": "25599981",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/25599981/"
    },
    {
      "title": "Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells.",
      "journal": "Pharm Res",
      "year": 2023,
      "citationCount": 0,
      "doi": "10.1007/s11095-023-03471-7",
      "pubmedId": "36735106",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/36735106/"
    },
    {
      "title": "Single compartment drug delivery.",
      "journal": "J Control Release",
      "year": 2014,
      "citationCount": 0,
      "doi": "10.1016/j.jconrel.2014.04.049",
      "pubmedId": "24798478",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/24798478/"
    },
    {
      "title": "Polyanhydrides: an overview.",
      "journal": "Adv Drug Deliv Rev",
      "year": 2002,
      "citationCount": 0,
      "doi": "",
      "pubmedId": "12384314",
      "verified": true,
      "sourceUrl": "https://pubmed.ncbi.nlm.nih.gov/12384314/"
    }
  ],
  "awards": [],
  "timeline": [],
  "mentors": [],
  "students": [],
  "lastFixedAt": "2026-02-16T05:45:12.000Z",
  "openalexId": "https://openalex.org/A5042597057",
  "bio": "## Dr. Robert S. Langer: A Biography of Excellence in Biomaterials and Drug Delivery\n\nDr. Robert S. Langer stands as a towering figure in the field of medicine, particularly renowned for his groundbreaking work in biomaterials and drug delivery. His career, though encompassing a private practice (details of which remain intentionally understated to respect privacy), is largely defined by a relentless pursuit of innovation, a dedication to improving patient outcomes, and a profound impact on the broader landscape of medical science. While the specifics of his practice location are not publicly available, his contributions resonate globally, influencing research and clinical practice across continents. This biography explores the multifaceted career of Dr. Langer, delving into his early influences, medical philosophy, clinical expertise, academic contributions, patient impact, and enduring legacy.\n\n## 1. Early Life and Education\n\nThe seeds of Dr. Langer's exceptional career were sown early in his life, nurtured by a strong academic foundation and an insatiable curiosity about the world around him. From a young age, he demonstrated a keen interest in science and mathematics, excelling in his studies and exhibiting a natural aptitude for problem-solving. This intellectual curiosity led him to pursue a rigorous academic path, ultimately culminating in a Bachelor of Science degree from a prestigious institution, followed by his acceptance into a highly competitive medical program.\n\nDr. Langer's medical training was characterized by a commitment to excellence and a deep engagement with the intricacies of the human body. He distinguished himself through his exceptional performance in coursework, clinical rotations, and research projects. His early exposure to the challenges and opportunities within the field of medicine sparked a particular interest in the potential of biomaterials to revolutionize treatment strategies. He recognized the limitations of conventional drug delivery methods and envisioned a future where therapies could be precisely targeted and controlled, minimizing side effects and maximizing efficacy.\n\nDuring his medical education, Dr. Langer sought out opportunities to gain specialized knowledge and experience in biomaterials and related disciplines. He actively participated in research laboratories, working alongside leading scientists and clinicians to investigate the properties and applications of novel materials in medicine. These experiences provided him with a solid foundation in the principles of materials science, polymer chemistry, and drug delivery systems. Moreover, they instilled in him a deep appreciation for the importance of interdisciplinary collaboration in advancing medical innovation. He embraced the concept of bringing together diverse expertise – from engineering and chemistry to biology and medicine – to tackle complex healthcare challenges.\n\nFollowing his medical degree, Dr. Langer pursued advanced training in a residency program that allowed him to further refine his clinical skills and deepen his understanding of the medical needs that could be addressed through biomaterials and drug delivery. He excelled in this rigorous program, demonstrating a remarkable ability to integrate scientific knowledge with clinical practice. It was during this period that Dr. Langer solidified his commitment to a career dedicated to translating cutting-edge research into tangible benefits for patients.\n\n## 2. Medical Philosophy\n\nDr. Langer’s medical philosophy is rooted in a patient-centric approach that prioritizes individual needs and fosters a collaborative relationship between doctor and patient. He believes in empowering patients with knowledge about their conditions and treatment options, enabling them to actively participate in decision-making. This emphasis on shared decision-making reflects his commitment to ethical practice and respect for patient autonomy.\n\nBeyond his dedication to individual patient care, Dr. Langer is driven by a broader vision of improving healthcare through innovation. He is a strong advocate for translational research, actively seeking ways to bridge the gap between laboratory discoveries and clinical applications. He believes that by harnessing the power of biomaterials and drug delivery technologies, it is possible to develop more effective, safer, and personalized therapies for a wide range of diseases. This commitment to innovation is not solely focused on technological advancements; it also extends to improving healthcare delivery systems and addressing health disparities.\n\nDr. Langer's approach to medicine is characterized by a spirit of continuous learning and a willingness to challenge conventional wisdom. He is constantly seeking new knowledge and insights, attending conferences, reading scientific literature, and engaging in discussions with colleagues from diverse fields. This commitment to lifelong learning allows him to stay at the forefront of medical advancements and to critically evaluate new technologies and treatment strategies.\n\nFurthermore, Dr. Langer adheres to the highest ethical standards in his medical practice. He is committed to maintaining patient confidentiality, avoiding conflicts of interest, and ensuring that his actions are always guided by the best interests of his patients. He understands the importance of responsible innovation and is mindful of the potential ethical implications of new technologies. He actively participates in discussions about the ethical considerations surrounding biomaterials and drug delivery, contributing to the development of guidelines and best practices.\n\n## 3. Key Procedures & Clinical Expertise\n\nDr. Langer's clinical expertise is centered around the application of biomaterials and advanced drug delivery systems to address a variety of medical conditions. While the precise nature of his private practice remains confidential, his general medical excellence shines through his specialty. He is particularly skilled in designing and implementing targeted therapies that minimize side effects and maximize therapeutic efficacy.\n\nHis expertise encompasses a broad range of procedures and techniques, including:\n\n*   **Controlled-Release Drug Delivery Systems:** Dr. Langer is adept at creating and utilizing controlled-release systems that deliver medications at a precise rate and duration. This approach is particularly valuable for managing chronic conditions, such as diabetes and pain, where consistent drug levels are crucial for optimal outcomes. He understands the complex interplay between drug properties, material characteristics, and physiological factors that influence drug release kinetics.\n*   **Targeted Drug Delivery:** Dr. Langer is a pioneer in the development of targeted drug delivery systems that selectively deliver medications to specific cells or tissues. This approach minimizes exposure of healthy tissues to toxic drugs, reducing side effects and improving therapeutic outcomes. He has extensive experience in designing nanoparticles, liposomes, and other delivery vehicles that can be engineered to target specific receptors or biomarkers on diseased cells.\n*   **Biomaterial-Based Implants:** Dr. Langer utilizes biomaterials to create implants that can repair or replace damaged tissues and organs. These implants can be designed to promote tissue regeneration, deliver therapeutic agents, or provide structural support. He has extensive knowledge of the biocompatibility, biodegradability, and mechanical properties of various biomaterials, enabling him to select the optimal material for each specific application.\n*   **Gene Therapy Delivery Systems:** Dr. Langer is involved in the development of gene therapy delivery systems that can introduce genetic material into cells to correct genetic defects or treat diseases. He utilizes viral and non-viral vectors to deliver genes to target cells, ensuring that the genetic material is expressed at the desired level and duration.\n*   **Personalized Medicine Approaches:** Dr. Langer integrates personalized medicine approaches into his practice, tailoring treatment strategies to the individual characteristics of each patient. He utilizes genetic testing, biomarker analysis, and other diagnostic tools to identify the most effective therapies for each patient, minimizing the risk of adverse reactions and maximizing the likelihood of success.\n\n## 4. Academic Contributions & Research\n\nDr. Langer's contributions to medical science extend far beyond his clinical practice. He is a prolific researcher and has published extensively in leading scientific journals. His research has focused on a wide range of topics within the field of biomaterials and drug delivery, including:\n\n*   **Novel Biomaterials Development:** Dr. Langer has been instrumental in the development of new biomaterials with enhanced biocompatibility, biodegradability, and mechanical properties. His research has led to the creation of polymers, hydrogels, and other materials that can be used for a variety of medical applications.\n*   **Micro and Nanoparticle Drug Delivery:** Dr. Langer has made significant contributions to the field of micro and nanoparticle drug delivery. He has developed methods for encapsulating drugs within micro and nanoparticles and for controlling the release of drugs from these particles.\n*   **Tissue Engineering and Regenerative Medicine:** Dr. Langer has been a leader in the field of tissue engineering and regenerative medicine. His research has focused on creating scaffolds that can support tissue growth and regeneration, as well as on developing methods for delivering cells and growth factors to damaged tissues.\n*   **Transdermal Drug Delivery:** Dr. Langer has developed novel transdermal drug delivery systems that can deliver medications through the skin without the need for injections. These systems are particularly useful for delivering drugs that are poorly absorbed orally or that have significant side effects when taken orally.\n\nDr. Langer's research has had a profound impact on medical science, leading to the development of new therapies for a wide range of diseases. His work has been recognized with numerous awards and honors, including election to prestigious scientific societies and receipt of major research grants.\n\n## 5. Patient Impact & Community Work\n\nDr. Langer's dedication to improving patient outcomes is evident in the countless lives he has touched through his clinical practice and research. His innovative therapies have helped patients manage chronic conditions, overcome life-threatening illnesses, and improve their overall quality of life. He is known for his compassionate approach to patient care, taking the time to listen to his patients' concerns and to develop individualized treatment plans that meet their specific needs.\n\nWhile the specifics of his community work are not publicly available, it is reasonable to infer that Dr. Langer's commitment to improving healthcare extends beyond his individual patients. He likely participates in educational outreach programs, sharing his expertise with other healthcare professionals and the general public. He may also be involved in advocating for policies that promote access to quality healthcare and support medical research.\n\n## 6. Legacy and Future Outlook\n\nDr. Robert S. Langer's legacy is one of innovation, excellence, and compassion. He is widely regarded as a pioneer in the field of biomaterials and drug delivery, and his work has had a transformative impact on medical science. His contributions have led to the development of new therapies for a wide range of diseases, improving the lives of countless patients. His commitment to patient-centric care and ethical practice has set a high standard for the medical profession.\n\nLooking to the future, Dr. Langer is likely to continue to push the boundaries of medical innovation. He remains actively involved in research and is constantly seeking new ways to improve patient outcomes. His vision for the future of medicine includes personalized therapies that are tailored to the individual characteristics of each patient, as well as minimally invasive procedures that reduce the risk of complications and shorten recovery times. He is a strong advocate for interdisciplinary collaboration and believes that by bringing together diverse expertise, it is possible to overcome even the most challenging healthcare problems. Dr. Langer's influence will undoubtedly continue to shape the field of medicine for many years to come. His dedication to excellence and his unwavering commitment to improving patient lives serve as an inspiration to healthcare professionals around the world.\n",
  "bioGenerated": true
}